Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 200-219 of 592


Jeremy Hunt launches genomics body to oversee healthcare revolutionby Randeep RameshThe GuardianJuly 4th, 2013Genomics England will aim to attract private investment in life sciences, but campaigners raise patient privacy concerns.
From Suspects to the Spitterati: A collision of power, profit, and privacyby Jessica CussinsBiopolitical TimesJune 27th, 2013DNA collection is increasingly ubiquitous, and the push for access to genetic information is gaining momentum. What questions should we be considering?
More Reactions to the Supreme Court's Gene Patent Decisionby Pete ShanksBiopolitical TimesJune 26th, 2013The unanimous Supreme Court decision that human genes may not be patented continues to provoke comment and speculation, some of it contradictory.
A New High-Tech, Grass-Roots Effort to Fight Breast Cancerby Apoorva MandavilliSlateJune 25th, 2013A volunteer effort is trying to "Free the Data" so that scientists everywhere can analyze Myriad's data and help women make informed choices about their breast-cancer risk.
Pioneering Icelandic Genetics Company Denied Approval for Data-Mining Planby Jocelyn KaiserScienceJune 20th, 2013A national agency that oversees data privacy in Iceland has rejected a request from deCODE to allow it to estimate the genotypes of 280,000 Icelanders who have never agreed to take part in the company's research.
Public Invasion of Genetic Privacy For UK Royal Family?by Dr Philippa BricePHG FoundationJune 17th, 2013A front-page story based on DNA analysis of distant cousins reveals that Prince William and Prince Harry have Indian ancestry, raising ethical concerns about genetic privacy.
Poking Holes in Genetic Privacyby Gina KolataThe New York TimesJune 16th, 2013For years now, a steady stream of research has eroded scientists’ faith that DNA can be held anonymously.
After Patent Ruling, Availability of Gene Tests Could Broadenby Andrew PollackThe New York TimesJune 13th, 2013Almost immediately after the Supreme Court ruled that human genes could not be patented, several laboratories announced they, too, would begin offering genetic testing for breast cancer risk.
Reactions to the Supreme Court Ruling Against Myriadby Pete ShanksBiopolitical TimesJune 13th, 2013The unanimous Supreme Court decision that human genes may not be patented was greeted with enthusiasm by the large coalition of plaintiffs and supporters, while the losers tried to put a brave face on it.
Supreme Court Strikes Down Gene Patentsby Pete Shanks and Marcy DarnovskyBiopolitical TimesJune 13th, 2013The Supreme Court's ruling against Myriad Genetics is a triumph for common sense and the common good, and for scientific research and legal fundamentals as well.
Supreme Court Rules Human Genes May Not Be Patentedby Adam LiptakThe New York TimesJune 13th, 2013Isolated human genes may not be patented, the Supreme Court ruled unanimously on Thursday.
Be Prepared for the Big Genome Leakby Steven E. BrennerNatureJune 12th, 2013Concerns are growing about our ability to properly control access to the information held in genetic research databases.
Size Mattersby Abby Lippman, Biopolitical Times guest contributorJune 11th, 2013Even if there really is a way to use telomere length to predict lifespans, this mirror into our inner workings raises troubling questions.
What Happened When I Had My Genome Sequencedby Carole CadwalladrThe Guardian June 8th, 2013"I was sanguine about having my genome sequenced but maybe that's my faulty risk calculation."
What Clinical Geneticists Think About DTC Genetic Testingby Dr Philippa BricePHG FoundationMay 31st, 2013A survey of over 100 European clinical geneticists reveals general opposition to the way in which direct-to-consumer genetic testing is delivered by commercial providers.
Genetic Tests: Who Should Know and Who Should Tell?by Pete ShanksBiopolitical TimesMay 29th, 2013The guidelines about "incidental findings" from genetic tests recently proposed by American College of Medical Genetics and Genomics continue to provoke debate, as does the broad concept of routine whole-genome analysis.
Cancer Inc.by Jessica CussinsBiopolitical TimesMay 28th, 2013Angelina Jolie’s widely discussed op-ed about her preventative double mastectomy glosses over the impact of one company’s patent on the “breast cancer genes” as well as alternative choices that are available to women who have mastectomies.
California Bill Would Prevent Genetic-Testing Firms from Using Surreptitiously Obtained DNAby Jessica ShugartMercury NewsMay 23rd, 2013Under current California law, genetic testing companies can reveal your most intimate biological secrets to anybody, without your knowledge or permission. A new bill may change that.
Angelina Jolie, Breast Cancer, and You: How to Make the Right Decisions for YOUR Healthby Judy NorsigianOur Bodies Our BlogMay 17th, 2013It is now up to women’s health advocates to ensure that media coverage and public debate don't offer false information or false hope.
Gene-Testing Dispute Focuses on How Much a Patient Should Knowby John LauermanBloombergMay 16th, 2013Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they don’t request the information?
Displaying 200-219 of 592  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760